Soft Tissue Sarcoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
Condition: High-Risk Localized Soft Tissue Sarcoma Interventions: Drug: Pegylated Liposomal Doxorubicin; Drug: Doxorubicin; Drug: Anti-PD-1 monoclonal antibody; Radiation: Radiotherapy Sponsor: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2023 Category: Research Source Type: clinical trials
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma Intervention: Drug: Tigilanol Tiglate Sponsor: QBiotics Group Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
